Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01333644 · ClinicalTrials.gov registry record
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 270
- Enrollment target
NCT01333644 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 270 participants.
The verdict
NCT01333644 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 270 participants
- Enrollment target
Study Summary
It is the central hypothesis of the investigators study that HIV disease is a pro-inflammatory condition, and that years of inflammation result in premature "aging' of the immune system ("immunosenescence"). Just as these changes are thought be causally associated with heart disease in the very old,the investigators postulate that these changes will be associated with early heart disease in the untreated and perhaps treated HIV disease. To address this hypothesis, the investigators will measure immunosenescence in a large cohort of patients who span the entire disease process.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01333644
The ClinicalTrials.gov registry entry for NCT01333644 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01333644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01333644 about?
NCT01333644 is a clinical study titled "The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk". It is the central hypothesis of the investigators study that HIV disease is a pro-inflammatory condition, and that years of inflammation result in premature "aging' of the immune system ("immunosenescence"). Just as these changes are thought be causally associated with heart disease in the very old,...
What is the current status of trial NCT01333644?
This trial is currently completed. The enrollment target is 270 participants. The study started on 2010-04. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01333644?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.